// company-profile
BioXcel Therapeutics, Inc.
BTAI// activity-summary
Recent insider activity is bullish. Over the last 30 days, 8 insiders purchased shares. Buying was led by Mehta Vimal.
// 90-day insight
Over the last 90 days, BioXcel Therapeutics, Inc. insiders bought $0 across 24 transactions with no open-market sales.
- Most active insider: Mehta Vimal with 7 transactions totaling $21K.
- Largest single sale: $21K by Mehta Vimal on May 20, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of BioXcel Therapeutics, Inc. as of 2026-03-31
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Mehta Vimal | BTAI | Option Exercise | 219 | — | — |
| Jun 15, 2026 | Mehta Vimal | BTAI | Option Exercise | 219 | $0.00 | $0K |
| Jun 15, 2026 | Yocca Frank | BTAI | Option Exercise | 35 | — | — |
| Jun 15, 2026 | Rodriguez Javier | BTAI | Option Exercise | 35 | $0.00 | $0K |
| Jun 15, 2026 | Steinhart Richard I | BTAI | Option Exercise | 35 | $0.00 | $0K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.